What is a CAP Score in Huntington's Disease?
At a Glance
In Huntington's disease, a CAP score (CAG-Age Product) is a calculation that multiplies your age by your excess CAG repeats. It estimates your lifetime exposure to the mutant protein. Researchers use it to track disease progression and determine clinical trial eligibility.
A CAP score, which stands for CAG-Age Product, is a mathematical formula used by researchers to estimate a person’s cumulative exposure to the mutant huntingtin protein over their lifetime [1]. If you have the gene expansion for Huntington’s disease (HD), the CAP score combines your current age with your specific CAG repeat number to estimate disease progression and how close you might be to developing noticeable symptoms [2]. While your CAG repeat number stays exactly the same throughout your life, your CAP score increases every year as you get older [1].
How is a CAP Score Calculated?
The basic formula for a CAP score multiplies your age by your “excess” CAG repeats [1]. Everyone has CAG repeats in their HTT gene, but in HD, this repeat is expanded. Researchers calculate the “excess” by taking your total CAG number and subtracting a baseline constant number (usually around 30, though some research models use 33.66) [1].
Example Calculation: If a person is 40 years old and has 42 CAG repeats, and the researcher uses a baseline of 30, their “excess” repeats would be 12 (42 minus 30). The CAP score would be their age (40) multiplied by their excess repeats (12), resulting in a score of 480 [1]. Because different research sites may use slight variations of this formula, your score might look a bit different depending on the specific study.
Because it accounts for the passage of time, the CAP score provides a much more accurate index of disease progression than looking at your CAG repeat number alone [2][1]. Think of it like sun exposure: your CAG number is how strong the sun is, and your age is how long you’ve been standing outside. The CAP score estimates the total amount of “sun” (mutant protein) you’ve been exposed to over time [1].
Why Do Doctors and Researchers Use It?
You will most commonly hear about CAP scores if you are looking into participating in a clinical trial or observational research [3]. Researchers use these scores to:
- Group Participants by Risk: For individuals who do not yet have symptoms (premanifest), CAP scores help divide them into low, medium, and high-risk groups [4]. This describes the statistical probability that they will develop motor symptoms within a certain timeframe, such as the next 5 to 10 years [3].
- Determine Biological Staging: Researchers increasingly use systems like the Huntington’s Disease Integrated Staging System (HD-ISS) to categorize the disease. The CAP score is a key tool used in these systems to define early stages before obvious symptoms appear [3].
- Track Biological Changes: CAP scores strongly correlate with physical changes in the brain that can be seen on MRI scans years before any physical symptoms emerge [5]. These changes include gradual shifts in brain volume which researchers track to see if a new drug is successfully slowing down the disease [6].
- Monitor Progression After Diagnosis: While mostly discussed as a predictive tool for premanifest individuals, researchers also use CAP scores in those who already have an official diagnosis to track ongoing disease burden and functional decline [7].
What Does the Number Mean for You?
Recently, researchers proposed a standardized version of the CAP score [1]. In this system, a score of 100 represents the statistically expected age when a person will receive an official diagnosis based on motor symptoms [1].
However, it is crucial to remember that a CAP score is just a statistical estimate based on large groups of people [1]. It is not a crystal ball for your individual timeline, and doctors strongly advise against treating a calculated score as a personal countdown clock. Two people with the exact same CAP score might develop symptoms years apart because other genetic modifiers, environmental factors, and lifestyle choices also heavily influence when Huntington’s disease begins [1].
Common questions in this guide
How do you calculate a CAP score for Huntington's disease?
Does my CAP score change over time?
What does a CAP score of 100 mean?
Why do doctors use the CAP score instead of just the CAG number?
Will my CAP score tell me exactly when my Huntington's symptoms will start?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Understanding the score
What does my CAP score actually tell me about my timeline?
Research participation
Would a CAP score matter if I am looking into joining a clinical trial?
Brain imaging
Would an MRI show brain changes that relate to a CAP score?
Related questions
Show more
Get notified when new evidence is published on Huntington disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
Standardizing the CAP Score in Huntington's Disease by Predicting Age-at-Onset.
Warner JH, Long JD, Mills JA, et al.
Journal of Huntington's disease 2022; (11(2)):153-171 doi:10.3233/JHD-210475.
PMID: 35466943 - 2
Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington's disease.
Liu CF, Younes L, Tong XJ, et al.
Brain communications 2023; (5(5)):fcad214 doi:10.1093/braincomms/fcad214.
PMID: 37744022 - 3
Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration.
Shaffer JJ, Ghayoor A, Long JD, et al.
Human brain mapping 2017; (38(3)):1460-1477 doi:10.1002/hbm.23465.
PMID: 28045213 - 4
MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study.
Reed ER, Latourelle JC, Bockholt JH, et al.
Neurology 2018; (90(4)):e264-e272 doi:10.1212/WNL.0000000000004844.
PMID: 29282329 - 5
Disease Progression in Huntington Disease: An Analysis of Multiple Longitudinal Outcomes.
Garcia TP, Wang Y, Shoulson I, et al.
Journal of Huntington's disease 2018; (7(4)):337-344 doi:10.3233/JHD-180297.
PMID: 30400103 - 6
Interplay between Sex and Disease Burden in Huntington's Disease: Clinical and Neuroimaging Perspectives.
Yao J, Feng B S G, Shao M S G, et al.
medRxiv : the preprint server for health sciences 2024; doi:10.1101/2024.10.31.24315900.
PMID: 39574844 - 7
Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.
Vinther-Jensen T, Simonsen AH, Budtz-Jørgensen E, et al.
European journal of neurology 2015; (22(10)):1378-84 doi:10.1111/ene.12750.
PMID: 26073975
This page explains CAP scores in Huntington's disease for educational purposes only. It is not a substitute for professional medical advice, and a CAP score should not be used as a personal timeline for your health.